• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    MediciNova Inc. (MNOV)

    -NasdaqGM
    6.88 Down 0.10(1.43%) Apr 29, 4:00PM EDT
    ProfileGet Profile for:
    MediciNova Inc.
    4275 Executive Square
    Suite 650
    La Jolla, CA 92037
    United States - Map
    Phone: 858-373-1500
    Fax: 858-404-0048
    Website: http://www.medicinova.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:N/A

    Business Summary 

    MediciNova, Inc., a biopharmaceutical company, focuses on acquiring and developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. Its product candidates include MN-166 (ibudilast), an anti-inflammatory and neuroprotective agent for the treatment of neurological disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, and substance dependence; MN-221 (bedoradrine), a ß2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound for the treatment of fibrotic diseases, such as nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a novel tubulin binding agent for the treatment of solid tumor cancers. MediciNova, Inc. was founded in 2000 and is based in La Jolla, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on MediciNova Inc.

    Key Executives 
     PayExercised
    Dr. Yuichi Iwaki M.D., Ph.D., 66
    Co-Founder, Chief Exec. Officer, Pres and Exec. Director
    794.00K0.00
    Mr. Masatsune Okajima , 48
    Head of Japanese Office and VP
    423.00K0.00
    Dr. Kazuko Matsuda M.D., Ph.D., MPH, 50
    Chief Medical Officer
    474.00K0.00
    Mr. Geoffrey G. O'Brien J.D., M.B.A., 47
    VP
    362.00K0.00
    Mr. Ryan J. Selhorn , 34
    Chief Financial Officer and Principal Accounting Officer
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders